Media Releases
» Go to news mainDal researcher invents chemo delivery system that minimizes impact on healthy cells
A researcher at Dalhousie Medical School has developed a new way to deliver chemotherapy drugs. Using nanotechnology, the novel system releases chemo in cancerous cells only, leaving healthy cells alone. The work was recently published in Nature’s Scientific Reports.
Dr. Naga Puvvada, a postdoctoral fellow at Dalhousie Medicine New Brunswick (DMNB), created the drug delivery system. He worked in collaboration with DMNB’s Dr. Keith Brunt and researchers in the United States and India.
The research team designed a nano-particle that increases the amount of chemotherapy delivered to a tumour, and releases chemo only once inside tumour cells. This minimizes the impact on healthy tissue.
Only with the high level of acidity created by tumours does the nano-particle become activated – it then enters the cancerous cell and breaks open. As the nano-particle releases its chemotherapy, it undergoes a colour change, known as photo-switching. This photo-switching enables researchers to determine how much of the chemo has been released and can be used to identify the presence of tumours.
“What ‘s unique about our design is the potential clinical translatability of our fluorescent photo-switching, as it could help determine the amount of chemotherapy being released,” says Dr. Puvvada. “We still have some work to do before this is used in the clinic as the fluorescence is not currently picked up by MRIs or CTs. This is one of the next steps in our research.”
While the research was based on human breast cancer cells, it has the potential to be applied to any solid tumour.
“This new delivery system, while it is in its early stages, is promising for patient-tailored therapy in personalized medicine,” says Dr. Brunt, assistant professor in the Department of Pharmacology. “The potential to improve the quality of life for solid tumour cancer patients and their overall outcomes is within reach with this type of targeted, measurable treatment.”
The research was funded by the New Brunswick Health Research Foundation, the Reynolds Fellowship, and the Canadian Natural and Engineering Research Council.
-30-
For more information:
View Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression at nature.com/scientificreports.
Images
 |
Dr. Naga Puvvada (left), a postdoctoral fellow at Dalhousie Medicine New Brunswick (DMNB) and DMNB’s Dr. Keith Brunt (right). July 2015 |
 |
Dr. Naga Puvvada (left) and Dr. Keith Brunt (right). July 2015 |
Media Contact
Allison Gerrard
Dalhousie Medical School
1 (902) 222-1917
allison.gerrard@dal.ca
Recent News
- Media Release: Cognitive behavioural program co‑developed by Dalhousie University researcher yields promising results in preventing transition to substance use disorders in teenagers
- Media opportunity: Single‑celled organisms with superpowers shown to buffer fertilizer input into the world's oceans by storing large amounts of nitrogen and phosphate and fighting harms to the marine environment
- Media Release: Dalhousie University receives $32M to lead national network for innovation, commercialization and entrepreneurship skills training
- Media opportunity: New lithium‑ion battery material for EVs and studied by Dalhousie University lasts for 10 times more charge‑discharge cycles compared to a conventional battery, potentially powering cars for eight million kilometres
- Media release: Dalhousie University researchers seek to improve quality of life of long‑term cancer patients after receiving funds from a Terry Fox research program developed by cancer patients for cancer patients
- Media release: Promising new treatment for older adults with depression and anxiety: Canadian study shows older adults experiencing depression, anxiety benefit from cognitive behavioural therapy tailored to their age group
- Media opportunity: The serious side of Christmas trees: They bring joy to the holiday season, but your festive tree also plays a serious role in sequestering carbon and mitigating greenhouse gas emissions
- Media opportunity: Dalhousie University researchers use novel measure to assess effects of vaping on young adults' lungs, finding e‑cigarette users impair lung function